FDANonrulemakingFDA-2024-D-3863

Who commented on this docket

Recommendations to Reduce the Risk of Transmission of Mycobacterium Tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Guidance for Industry; Availability

1 organizations filed 1 public comment on Recommendations to Reduce the Risk of Transmission of Mycobacterium Tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 386d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 386d ago

Abstract

Open

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.